多西环素在降低COVID-19重症患者血栓形成和死亡率方面的潜在作用:一个多中心队列研究
Khalid Al Sulaiman1,2,3,4, Ohoud Aljuhani5, Ghazwa B Korayem6
1Pharmaceutical Care Department, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
概括
多西环素可能会降低重症COVID-19患者的血栓事件和死亡率. 这种抗生素显示出潜在的益处,包括降低D-二聚物水平和降低肺炎风险,表明其在重症监护中的价值.
科学领域:
- 关键护理医学 关键护理医学
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 在动物模型中,多西环林在预防血栓形成和降低死亡率方面表现有前途.
- 关于多西环林在COVID-19患者的抗血栓作用的数据有限.
研究的目的:
- 为了评估多西环林对重症COVID-19患者临床结果的影响.
- 评估多西环林在减少血栓事件和死亡率方面的作用.
主要方法:
- 多中心回顾性队列研究 (2020年3月 - 2021年7月).
- 倾向性得分匹配 (1:3) 将多西环林接受者与在重症监护室 (ICU) 的对照者进行比较.
- 综合性血栓事件,死亡率,停留时间,无呼吸器的日子和并发症的分析.
主要成果:
- 较低,但在统计学上没有显著的血栓栓塞事件在多西环林组 (OR:0.54).
- 在接受多西环林的患者中,降低了D-二元水平 (β: -0.22) 和30天死亡率 (HR: 0.73).
- 在多西环林组中,细菌/真菌肺炎的几率显著降低 (OR:0.65).
结论:
- 多西环素可能为重症COVID-19患者提供治疗效益.
- 辅助多西环林治疗显示出降低血栓形成和改善生存率的潜力.
- 需要进一步的研究来证实多西环林在这种患者群体中的有效性.
相关概念视频
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
Myocarditis III: Medical Management
9
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
9
Acute Coronary Syndrome IV: Interprofessional Care
13
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
13
Venous Thrombosis III: Interprofessional Care
11
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
11
Endocarditis III: Medical Management
8
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
8
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
568
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
568


